Created at the UW–Madison School of Pharmacy, Med Wise Rx is helping older adults understand their medications — and advocate for themselves.
Created at the UW–Madison School of Pharmacy, Med Wise Rx is helping older adults understand their medications — and advocate for themselves.
The UW–Madison School of Pharmacy’s PearlRx — the nation’s largest research network of its kind — connects pharmacists and researchers to improve Wisconsin practice.
Professor Barry Gidal, a nationally recognized leader in epilepsy research, is driving progress in treatment and patient advocacy.
Professor Lingjun Li and lab members reveal the crucial role of neuropeptides in cocaine addiction, paving the way for novel therapies.
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
Groundbreaking research from School of Pharmacy faculty reveals alarming misuse of OTC medications by older adults and offers a simple solution.
Professors Timothy Bugni, Lingjun Li, and Weiping Tang have received UW–Madison grants to advance their innovative multidisciplinary research.